Menu
Back to Archived Journals » Neurobehavioral HIV Medicine
Neurobehavioral HIV Medicine ceased publishing in January 2017. All new submissions can be made to HIV/AIDS - Research and Palliative Care. All articles that have been published in Neurobehavioral HIV Medicine will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Neurobehavioral HIV Medicine
ISSN: 1179-1497
- View all (38)
- Volume 7, 2016 (5)
- Volume 6, 2015 (1)
- Volume 5, 2013 (2)
- Volume 4, 2012 (8)
- Volume 3, 2011 (9)
- Volume 2, 2010 (10)
- Volume 1, 2009 (3)
Journal Articles:
- 38 records -
Chronic distress and the vulnerable host: a new target for HIV treatment and prevention?
Contoreggi C, Chrousos GP, Di Mascio M
Neurobehavioral HIV Medicine 2016, 7:53-75
Published Date: 28 December 2016
HIV-associated progressive multifocal leukoencephalopathy: current perspectives
Iannetta M, Zingaropoli MA, D’Abramo A, Oliva A, Mastroianni CM, Vullo V, Ciardi MR
Neurobehavioral HIV Medicine 2016, 7:43-52
Published Date: 8 August 2016
Evidence-based perspectives on the implementation of screening for neurocognitive impairment in HIV
Haddow LJ, Barber TJ, Breuer L, Cartledge JD, Pierce K
Neurobehavioral HIV Medicine 2016, 7:31-41
Published Date: 4 August 2016
Prevalence, impact, and management of depression and anxiety in patients with HIV: a review
Chaudhury S, Bakhla AK, Saini R
Neurobehavioral HIV Medicine 2016, 7:15-30
Published Date: 5 May 2016
Neurodevelopmental delay in pediatric HIV/AIDS: current perspectives
Blokhuis C, Kootstra NA, Caan MW, Pajkrt D
Neurobehavioral HIV Medicine 2016, 7:1-13
Published Date: 13 January 2016
Neuropsychological profile in a specific cohort of HIV patients infected postnatally: a cross-sectional study
Riva S, Cutica I, Pravettoni G
Neurobehavioral HIV Medicine 2015, 6:1-6
Published Date: 9 October 2015
Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity
Panos SE, Hinkin CH, Singer EJ, Thames AD, Patel SM, Sinsheimer JS, Del Re AC, Gelman BB, Morgello S, Moore DJ, Levine AJ
Neurobehavioral HIV Medicine 2013, 5:11-22
Published Date: 19 June 2013
Neuropsychiatric effects of tenofovir in comparison with other antiretroviral drugs
Ferrer K, Rakhmanina N
Neurobehavioral HIV Medicine 2013, 5:1-10
Published Date: 22 January 2013
Baseline medication adherence and response to an electronically delivered health literacy intervention targeting adherence
Ownby RL, Waldrop-Valverde D, Caballero J, Jacobs RJ
Neurobehavioral HIV Medicine 2012, 4:113-121
Published Date: 18 October 2012
The neuro-ophthalmology of HIV-AIDS review of Neurobehavioral HIV Medicine
Sudhakar P, Kedar S, Berger JR
Neurobehavioral HIV Medicine 2012, 4:99-111
Published Date: 18 September 2012
HIV treatment: mechanisms of neurotoxicity and implications for targeted therapy
Wu C, Lu Y
Neurobehavioral HIV Medicine 2012, 4:75-98
Published Date: 4 September 2012
Management issues in HIV-associated neurocognitive disorders
Cysique LA, Bain MP, Lane TA, Brew BJ
Neurobehavioral HIV Medicine 2012, 4:63-73
Published Date: 11 July 2012
Prognosis and management of cryptococcal meningitis in patients with human immunodeficiency virus infection
Rhein J, Boulware DR
Neurobehavioral HIV Medicine 2012, 4:45-61
Published Date: 18 June 2012
Emerging viral and bacterial infections of the central nervous system
Balin BJ, Hammond CJ
Neurobehavioral HIV Medicine 2012, 4:35-44
Published Date: 1 May 2012
Substance abuse, hepatitis C, and aging in HIV: common cofactors that contribute to neurobehavioral disturbances
Schuster RM, Gonzalez R
Neurobehavioral HIV Medicine 2012, 4:15-34
Published Date: 15 February 2012
Immune activation and neuropsychiatric symptoms in human immunodeficiency virus type 1 infection
Schroecksnadel S, Kurz K, Weiss G, Fuchs D
Neurobehavioral HIV Medicine 2012, 4:1-13
Published Date: 16 January 2012
Stress management interventions for HIV-infected individuals: review of recent intervention approaches and directions for future research
Brown JL, Vanable PA
Neurobehavioral HIV Medicine 2011, 3:95-106
Published Date: 8 November 2011
Cognitive reserve masks neurobehavioral expression of human immunodeficiency virus-associated neurological disorder in older patients
Thames AD, Foley JM, Panos SE, Singer EJ, El-Saden S, Hinkin CH
Neurobehavioral HIV Medicine 2011, 3:87-93
Published Date: 31 October 2011
A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers
Levine AJ, Palomo M, Hinkin CH, Valdes-Sueiras M, Lopez E, Mathisen G, Donovan S, Singer EJ
Neurobehavioral HIV Medicine 2011, 3:79-86
Published Date: 26 September 2011
Gene expression for HIV-associated dementia and HIV encephalitis in microdissected neurons 1: preliminary analysis
Shapshak P, Duncan R, Duran EM, Farinetti F, Minagar A, Commins D, Rodriguez H, Chiappelli F, Kangueane P, Levine AJ, Singer E, Somboonwit C, Sinnott JT
Neurobehavioral HIV Medicine 2011, 3:53-78
Published Date: 19 July 2011
Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS
Singh KK, Nathamu S, Adame A, Alire TU, Dumaop W, Gouaux B, Moore DJ, Masliah E, and HNRC Group
Neurobehavioral HIV Medicine 2011, 3:41-52
Published Date: 30 May 2011
Anti-HIV-1 drug toxicity and management strategies
Sharma B
Neurobehavioral HIV Medicine 2011, 3:27-40
Published Date: 28 April 2011
Depression, alcohol abuse, and disclosure of HIV serostatus among rural HIV-positive individuals in western Uganda
Nakimuli-Mpungu E, Munyaneza G
Neurobehavioral HIV Medicine 2011, 3:19-25
Published Date: 14 April 2011
Development of neurocognitive disorders in HIV/AIDS
Brandon C Dennis, Sidney A Houff, Dong Y Han, et al
Neurobehavioral HIV Medicine 2011, 3:9-18
Published Date: 10 March 2011
Effect of older age at initiation of antiretroviral therapy on patient retention in an urban ART program in Uganda
Etheldreda Nakimuli-Mpungu, Noeline Nakasujja, Howard Dickens Akena, et al
Neurobehavioral HIV Medicine 2011, 3:1-8
Published Date: 16 December 2010
Cognitive function in treated HIV patients
Valerio Tozzi, Pietro Balestra, Raffaella Libertone, et al
Neurobehavioral HIV Medicine 2010, 2:95-113
Published Date: 16 November 2010
Impact of HIV infection and alcohol on cognition: a review
Ola A Selnes
Neurobehavioral HIV Medicine 2010, 2:85-94
Published Date: 20 October 2010
Depression care and prevalence in HIV-positive individuals
Raymond L Ownby, Robin J Jacobs, Drenna Waldrop-Valverde, et al.
Neurobehavioral HIV Medicine 2010, 2:73-83
Published Date: 30 August 2010
A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy-era of HIV central nervous system disease
Katrina A Morris, Nicholas WS Davies, Bruce J Brew
Neurobehavioral HIV Medicine 2010, 2:59-72
Published Date: 24 August 2010
Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status
Allison J Applebaum, Jacqueline R Bullis, Lara N Traeger, et al
Neurobehavioral HIV Medicine 2010, 2:49-57
Published Date: 11 August 2010
Relationships between the use of second-generation antipsychotics and changes in total cholesterol levels in children and adolescents perinatally infected with HIV
Suad Kapetanovic, Lisa Aaron, Paige L Williams, et al
Neurobehavioral HIV Medicine 2010, 2:39-48
Published Date: 4 August 2010
Amelioration of caspase 3,7 activity by SP01 in human primary neurons exposed to HIV
Amol Shah, Gursharan Chana, Ginger R Lucero, et al
Neurobehavioral HIV Medicine 2010, 2:33-37
Published Date: 14 July 2010
Exploration of a genomic expression and pathway analysis approach to neurocognitive performance: preliminary findings
Chad A Bousman, Gursharan Chana, Stephen J Glatt, et al
Neurobehavioral HIV Medicine 2010, 2:23-32
Published Date: 12 July 2010
Variable cognitive benefits in HAART-treated patients: are aging and low cholesterol linked?
María Jose Míguez-Burbano, John E Lewis, Ximena Burbano, et al
Neurobehavioral HIV Medicine 2010, 2:13-21
Published Date: 8 April 2010
Impact of COMT Val158Met on executive functioning in the context of HIV and methamphetamine
Chad A Bousman, Mariana Cherner, Stephen J Glatt, et al
Neurobehavioral HIV Medicine 2010, 2:1-11
Published Date: 14 January 2010
Alcohol use and gender effects on HIV risk behaviors in cocaine-using methadone patients
Carla J Rash, Nancy M Petry
Neurobehavioral HIV Medicine 2009, 1:25-32
Published Date: 20 November 2009
Gender and racial differences in risk factors for sexually transmitted diseases among justice-involved youth
Richard Dembo, Kristina Childs, Steven Belenko, et al
Neurobehavioral HIV Medicine 2009, 1:9-24
Published Date: 19 November 2009
CCL3 genotype and current depression increase risk of HIV-associated dementia
Andrew J Levine, Elyse J Singer, Janet S Sinsheimer, et al
Neurobehavioral HIV Medicine 2009, 1:1-7
Published Date: 17 November 2009